Spreadsheet: 080210f3-1af6-4192-8ed9-4a3413789965
Sheet: Sheet1

Test Referenced | Entry Type | Mayo ID | Description | Reporting Description | Method | Collection Container | Temperature | Stability | [NAME] | Unit of Measure | [NAME] | Minimum Volume | Reject Due To | Reference Values | Days/Times Performed | Analytic Time | Maximum Lab Time | CPT Units | CPT Code | LOINC® Code | LOINC® Attributes | Always Performed | Orderable Separately | Performing Location
DAU7 | Test | DAU7 | Drugs of Abuse Screen, DAU7, [NAME] | Drug of Abuse, Clin, DAU7, U | DAU7: Enzyme-Multiplied Immunoassay Technique (EMIT) MSOP: Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | [NAME]: Urine |  |  | 30 | mL | Container/Tube: Plastic, 60-mL urine container (Supply T313) [NAME]: 30 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 10 mL | Hemolysis	NA Thawing	Warm OK; Cold OK Lipemia	NA Icterus	NA Other	NA | Negative The specific drug identified will be reported. EMIT cutoff concentrations Amphetamines: 500 ng/mL Barbiturates: 200 ng/mL Benzodiazepines: 200 ng/mL Cocaine (benzoylecgonine-cocaine metabolite): 150 ng/mL Opiates: 300 ng/mL Phencyclidine: 25 ng/mL THC: 50 ng/mL Results of this test are confirmed and should be considered definitive. Specimens are normally kept for 2 weeks after Mayo Medical Laboratories New England receipt date. | Monday through Friday, Sunday | 1 day if negative 2 days if positive | 2 days | 1 | 80104 |  |  |  |  | New England
DAU7 | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
DAU7 | Result | 11164 | Amphetamines | Amphetamines | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 8150-5 | Amphetamines:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 11301 | Barbiturates | Barbiturates | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 9426-8 | Barbiturates:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 11572 | Benzodiazepines | Benzodiazepines | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 9428-4 | Benzodiazepines:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 11161 | [NAME] | [NAME] | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 3394-4 | Benzoylecgonine:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 11570 | Opiates | Opiates | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 8220-6 | Opiates:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 11573 | Phencyclidine | Phencyclidine | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 3937-0 | Phencyclidine:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 11162 | Tetrahydrocannabinols | Tetrahydrocannabinols | Numeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 3530-3 | Tetrahydrocannabinol:MCnc:Pt:[NAME]:Qn:
DAU7 | Result | 200209 | Comment | Comment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48767-8 | Annotation comment:Imp:Pt:{system}:Nar:
DAU7 | [NAME] | MSOP | Drugs of Abuse, Opiates Confirmation, [NAME] | Drug of Abuse, [NAME], U | Liquid Chromatography-Tandem Mass Spectrometry (LC-MS/MS) | [NAME]: Urine |  |  | 10 | mL | This test is not orderable individually, it is only available as part of OPIU/501196 Drug of Abuse (DAU), Opiates, [NAME], which includes a screen and confirmation.   Container/Tube: Plastic, 10-mL urine tube (Supply T068) [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 3 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Negative Positive cutoff concentrations Codeine: <100 ng/mL Hydrocodone: <100 ng/mL Hydromorphone: <100 ng/mL Morphine: <100 ng/mL Oxycodone: <100 ng/mL Oxymorphone: <100 ng/mL | Monday through Friday; 1st shift | 2 days | 5 days | 1 | 83925 |  |  | No | No
MSOP | [NAME] | URINE | [NAME] |  |  |  | Refrigerated
MSOP | Result | 11141 | Confirmation - Opiates | Confirmation - Opiates | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 17384-9 | Opiates:MCnc:Pt:[NAME]:Qn:Confirm
MSOP | Result | 200210 | Codeine | Codeine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16250-3 | Codeine:MCnc:Pt:[NAME]:Qn:Confirm
MSOP | Result | 200211 | Hydrocodone | Hydrocodone | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16252-9 | Hydrocodone:MCnc:Pt:[NAME]:Qn:Confirm
MSOP | Result | 200212 | Hydromorphone | Hydromorphone | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16998-7 | Hydromorphone:MCnc:Pt:[NAME]:Qn:Confirm
MSOP | Result | 200214 | [NAME] | [NAME] | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16251-1 | Morphine:MCnc:Pt:[NAME]:Qn:Confirm
MSOP | Result | 200213 | Oxycodone | Oxycodone | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16249-5 | Oxycodone:MCnc:Pt:[NAME]:Qn:Confirm
MSOP | Result | 200289 | Oxymorphone | Oxymorphone | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 17395-5 | Oxymorphone:MCnc:Pt:[NAME]:Qn:Confirm
DAU7 | [NAME] | DAUAM | Drug of Abuse, Amphetamines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | Gas Chromatography-Mass Spectrometry (GC-MS) | [NAME]: Urine |  |  | 10 | mL | Container/Tube: Plastic, 10-mL urine tube (Supply T068) [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 5 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Negative Positives for amphetamine, methamphetamine, methylenedioxymethamphetamine (MDMA), methylenedioxyamphetamine (MDA), and phentermine are reported with a quantitative GC-MS result. Positives for pseudoephedrine/ephedrine and phenylpropanolamine are reported qualitatively as present. [NAME] concentrations Amphetamine: <50 ng/mL Methamphetamine: <50 ng/mL MDMA ([NAME]): <50 ng/mL MDA (Ecstasy metabolite): <50 ng/mL [NAME] (qualitative only): negative <500 ng/mL not reported Pseudoephedrine/Ephedrine (qualitative only): negative <500 ng/mL not reported Phenylpropanolamine: <500 ng/mL | Varies; 3 times per week | 3 days | 5 days | 2 | 82145 |  |  | No | Yes
DAUAM | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
DAUAM | Result | 501207 | GC/MS Confirmation - Amphetamine | GC/MS Confirmation - Amphetamine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16234-7 | Amphetamine:MCnc:Pt:[NAME]:Qn:Confirm
DAUAM | Result | 501208 | Amphetamine | Amphetamine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16234-7 | Amphetamine:MCnc:Pt:[NAME]:Qn:Confirm
DAUAM | Result | 501209 | Methamphetamine | Methamphetamine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16235-4 | Methamphetamine:MCnc:Pt:[NAME]:Qn:Confirm
DAUAM | Result | 500197 | MDMA (Ecstasy) | MDMA (Ecstasy) | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 18358-2 | Methylenedioxymethamphetamine:MCnc:Pt:[NAME]:Qn:Confirm
DAUAM | Result | 501210 | MDA ([NAME]) | MDA ([NAME]) | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 27409-2 | Methylenedianiline:MCnc:Pt:[NAME]:Qn:
DAUAM | Result | 501211 | [NAME] | [NAME] | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 20557-5 | Phentermine:MCnc:Pt:[NAME]:Qn:Confirm
DAUAM | Result | 501212 | Pseudoephedrine/Ephedrine | Pseudoephedrine/Ephedrine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 26785-6 | Ephedrine+Pseudoephedrine:MCnc:Pt:[NAME]:Qn:
DAUAM | Result | 501213 | Phenylpropanolamine | Phenylpropanolamine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 17443-3 | Phenylpropanolamine:MCnc:Pt:[NAME]:Qn:
DAUAM | Result | 501214 | Comment | Comment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48767-8 | Annotation comment:Imp:Pt:{system}:Nar:
DAU7 | [NAME] | DAUBZ | Drug of Abuse, Benzodiazepines GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | Gas Chromatography-Mass Spectrometry (GC-MS) | [NAME]: Urine |  |  | 20 | mL | Container/Tube: Plastic, 10-mL urine bottle [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 5 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Negative Positives are reported with a quantitative GC-MS result. [NAME] concentrations Lorazepam: <100 ng/mL Nordiazepam: <100 ng/mL Oxazepam: <100 ng/mL Temazepam: <100 ng/mL Hydroxyethyl-flurazepam: <100 ng/mL 7-Amino-clonazepam: <100 ng/mL 7-Amino-flunitrazepam: <50 ng/mL Alpha-hydroxyalprazolam: <100 ng/mL Alpha-hydroxytriazolam: <100 ng/mL | Varies; 4 times per week | 2 days | 5 days | 1 | 80154 |  |  | No | Yes
DAUBZ | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
DAUBZ | Result | 501215 | GC/MS Confirmation - Benzodiazepine | GC/MS Confirmation - Benzodiazepine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20412-3 | Benzodiazepines:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501216 | Lorazepam | Lorazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 17088-6 | Lorazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501217 | Nordiazepam | Nordiazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16228-9 | Nordiazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501218 | Oxazepam | Oxazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16201-6 | Oxazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501219 | Temazepam | Temazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 20559-1 | Temazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501220 | OH-Ethyl-Flurazepam | OH-Ethyl-Flurazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 20532-8 | Hydroxyethylflurazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501221 | 7-NH-Clonazepam | 7-NH-Clonazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 51776-3 | 7-Aminoclonazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501222 | 7-NH-Flunitrazepam | 7-NH-Flunitrazepam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 51777-1 | 7-Aminoflunitrazepam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501223 | Alpha OH-Alprazolam | Alpha OH-Alprazolam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16348-5 | Alpha hydroxyalprazolam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501224 | Alpha-OH-Triazolam | Alpha-OH-Triazolam | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 49876-6 | Alpha hydroxytriazolam:MCnc:Pt:[NAME]:Qn:Confirm
DAUBZ | Result | 501225 | Comment | Comment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48767-8 | Annotation comment:Imp:Pt:{system}:Nar:
DAU7 | [NAME] | MSBR | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, Barbiturate Conf, U | Gas Chromatography-Mass Spectrometry (GC-MS) | [NAME]: Urine |  |  | 10 | mL | Container/Tube: Plastic, 10-mL urine tube (Supply T068) [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 5 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Positives are reported with a quantitative GC-MS result. [NAME] concentrations Amobarbital: <100 ng/mL Butalbital: <100 ng/mL Pentobarbital: <100 ng/mL Phenobarbital: <100 ng/mL Secobarbital: <100 ng/mL | Varies; 3 times per week | 3 days | 5 days | 1 | 82205 |  |  | No | Yes
MSBR | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
MSBR | Result | 2837 | GC/MS Confirmation - Barbiturate | GC/MS Confirmation - Barbiturate | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20411-5 | Barbiturates:MCnc:Pt:[NAME]:Qn:Confirm
MSBR | Result | 501226 | Amobarbital | Amobarbital | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16239-6 | Amobarbital:MCnc:Pt:[NAME]:Qn:Confirm
MSBR | Result | 501227 | Butalbital | Butalbital | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16237-0 | Butalbital:MCnc:Pt:[NAME]:Qn:Confirm
MSBR | Result | 501228 | Pentobarbital | Pentobarbital | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16240-4 | Pentobarbital:MCnc:Pt:[NAME]:Qn:Confirm
MSBR | Result | 501229 | Phenobarbital | Phenobarbital | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16241-2 | Phenobarbital:MCnc:Pt:[NAME]:Qn:Confirm
MSBR | Result | 501230 | Secobarbital | Secobarbital | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16238-8 | Secobarbital:MCnc:Pt:[NAME]:Qn:Confirm
MSBR | Result | 501225 | Comment | Comment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48767-8 | Annotation comment:Imp:Pt:{system}:Nar:
DAU7 | [NAME] | MSCO | Drug of Abuse, [NAME], [NAME] | Drug of Abuse, [NAME], U | Gas Chromatography-Mass Spectrometry (GC-MS) | [NAME]: Urine |  |  | 10 | mL | Container/Tube: Plastic, 10-mL urine tube [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 5 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Negative Positives are reported with a quantitative GC-MS result. [NAME] concentrations Cocaine: <50 ng/mL Benzoylecgonine: <50 ng/mL | Varies; 2 times per week | 3 days | 5 days | 1 | 82520 |  |  | No | Yes
MSCO | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
MSCO | Result | COCAC | GC/MS Confirmation - Cocaine | GC/MS Confirmation - Cocaine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20519-5 | Cocaine:MCnc:Pt:[NAME]:Qn:Confirm
MSCO | Result | COCUC | Cocaine | Cocaine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 20519-5 | Cocaine:MCnc:Pt:[NAME]:Qn:Confirm
MSCO | Result | BEUC | Benzoylecgonine | Benzoylecgonine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16226-3 | Benzoylecgonine:MCnc:Pt:[NAME]:Qn:Confirm
MSCO | Result | CMT94 | Comment | Comment | Alphanumeric
DAU7 | [NAME] | MSPCP | Drug of Abuse, Phencyclidine GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME] | Gas Chromatography-Mass Spectrometry (GC-MS) | [NAME]: Urine |  |  | 10 | mL | Container/Tube: Plastic, 10-mL urine tube (Supply T068) [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. Additional Information: No STAT testing performed for this assay. | 5 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Negative Positives are reported with a quantitative GC-MS result. [NAME] concentration: <10 ng/mL | Varies; 2 times per week | 3 days | 6 days | 1 | 83992 |  |  | No | Yes
MSPCP | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
MSPCP | Result | 11146 | GC/MS Confirmation - Phencyclidine | GC/MS Confirmation - Phencyclidine | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 16254-5 | Phencyclidine:MCnc:Pt:[NAME]:Qn:Confirm
MSPCP | Result | 501238 | Phencyclidine | Phencyclidine | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 16254-5 | Phencyclidine:MCnc:Pt:[NAME]:Qn:Confirm
MSPCP | Result | 501239 | Comment | Comment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48767-8 | Annotation comment:Imp:Pt:{system}:Nar:
DAU7 | [NAME] | MSTHC | Drug of Abuse, Tetrahydrocannabinol GC-MS Confirmation, [NAME] | Drug of Abuse, [NAME], U | Gas Chromatography-Mass Spectrometry (GC-MS) | [NAME]: Urine |  |  | 10 | mL | Container/Tube: Plastic, 10-mL urine bottle [NAME]: 10 mL Collection Instructions: 1. Collect a random urine specimen. 2. No preservative. | 5 mL | Hemolysis	NA Thawing	Warm OK; Cold OK  Lipemia	NA Icterus	NA Other	NA | Negative Positives are reported with a quantitative GC-MS result. [NAME] concentration: <3 ng/mL | Monday through Friday; 8 a.m. - 6 p.m. | 3 days | 5 days | 1 | 80299 |  |  | No | Yes
MSTHC | [NAME] | URINE | [NAME] |  |  |  | Refrigerated | 14 days
MSTHC | Result | 11145 | GC/MS Confirmation - THC | GC/MS Confirmation - THC | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 20413-1 | Cannabinoids:MCnc:Pt:[NAME]:Qn:Confirm
MSTHC | Result | 501233 | THC Carboxylic Acid | THC Carboxylic Acid | Alphanumeric |  |  |  |  | ng/mL |  |  |  |  |  |  |  |  |  | 3530-3 | Tetrahydrocannabinol:MCnc:Pt:[NAME]:Qn:
MSTHC | Result | 501234 | Comment | Comment | Alphanumeric |  |  |  |  |  |  |  |  |  |  |  |  |  |  | 48767-8 | Annotation comment:Imp:Pt:{system}:Nar: